Maribavir prevents CMV infection after stem cell transplant NEW YORK (Reuters Health) - Maribavir, a novel inhibitor of a viral protein kinase of human cytomegalovirus (CMV), reduces the incidence of CMV infection in allogeneic stem cell transplant recipients, according to a report in the June 1st...
Maribavir prevents CMV infection after stem cell transplant NEW YORK (Reuters Health) - Maribavir, a novel inhibitor of a viral protein kinase of human cytomegalovirus (CMV), reduces the incidence of CMV infection in allogeneic stem cell transplant recipients, according to a report in the June 1st...
Tobira Therapeutics Inc. Announces Senior Management Team PRINCETON, N.J.Palleja is the Chief Medical Officer, responsible for the overall clinical development of the Tobira Therapeutics portfolio.
Sandra joined Tobira from Shionogi USA, where she lead numerous clinical programs as Vice...
Tobira Therapeutics Inc. Announces Senior Management Team - Senior management team possessing over 130 years of cumulative expertise - -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering...
Tobira Therapeutics Inc. Announces Senior Management Team Senior management team possessing over 130 years of cumulative expertisePRINCETON, N.J.and SAN DIEGO, June 30 (HSMN NewsFeed) -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product...
::: Tobira Therapeutics Inc. Announces Senior Management Team - Senior management team possessing over 130 years of cumulative expertise - PRINCETON, N.J.and SAN DIEGO, June 30 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product...
Tobira Therapeutics Inc. Announces Senior Mana PRINCETON, N.J.and SAN DIEGO, June 30 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today...
Tobira Therapeutics Inc. Announces Senior Management Team PRINCETON, N.J.and SAN DIEGO, June 30 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today...
Tobira Therapeutics Inc. Announces Senior Management Team , 3:00 AM EST Dr.Palleja is the Chief Medical Officer, responsible for the overall clinical development of the Tobira Therapeutics portfolio.
Sandra joined Tobira from Shionogi USA, where she lead numerous clinical programs as Vice...
Tobira Therapeutics Inc. Announces Senior Management Team PRINCETON, N.J.and SAN DIEGO, June 30 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today...
Tobira Therapeutics Inc. Announces Senior Management Team PRINCETON, N.J.and SAN DIEGO, June 30 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today...
Tobira Therapeutics Inc. Announces Senior Management Team PRINCETON, N.J.and SAN DIEGO, June 30 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today...
Tobira Therapeutics Inc. Announces Senior Management Team PRINCETON, N.J.and SAN DIEGO, June 30 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today...
Tobira Therapeutics Inc. Announces Senior Management Team PRINCETON, N.J.and SAN DIEGO, June 30 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today...
Tobira Therapeutics Inc. Announces Senior Management Team PRINCETON, N.J.and SAN DIEGO, June 30 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today...
Tobira Therapeutics Inc. Announces Senior Management Team PRINCETON, N.J.and SAN DIEGO, June 30 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today...
Tobira Therapeutics Inc. Announces Senior Management Team - Senior management team possessing over 130 years of cumulative expertise - PRINCETON, N.J.and SAN DIEGO, June 30 PRINCETON, N.J.
and SAN DIEGO, June 30 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company...
Tobira Therapeutics Inc. Announces Senior Management Team PRINCETON, N.J.and SAN DIEGO, June 30 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today...
Tobira Therapeutics Inc. Announces Senior Management Team AM PRINCETON, N.J.and SAN DIEGO, June 30 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases,...
Sirion Therapeutics Announces FDA Approval of Durezol(TM) for Treatment of Postoperative Ocular Inflammation a Durezol is First Ophthalmic Steroid Indicated for Inflammation and Pain TAMPA, Fla., June 24 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that the U.S.Food and...
Quantitative analysis of clinically relevant mutations occurring in lymphoid cells harboring -retrovirus-enco The in vivo regulation of T lymphocyte activity by the activation of a suicide mechanism is an essential paradigm for the safety of adoptive cell therapies.In light of reports showing that -retroviral vector-encoded herpes simplex virus...
Improvement in Long-Term Renal Graft Survival Due to CMV Prophylaxis With Oral Ganciclovir: Results of a Rando _ Improvement in Long-Term Renal Graft Survival Due to CMV Prophylaxis With Oral Ganciclovir: Results of a Rando.
New brain cancer study findings have been published by scientists at University of California - (NewsRx.com) -- 'Glioblastoma multiforme (GBM) is an invasive and aggressive primary brain tumor which is associated with a dismal prognosis (see also Brain Cancer).We have earlier developed a macroscopic, intracranial, syngeneic GBM...
Genetically modified tumor-targeted bacteria with reduced virulence Title: United States Patent: 7,354,592 Inventors: Bermudes; David (Wallingford, CT), Low; Kenneth Brooks (Guilford, CT) Assignee: Vion Pharmaceuticals, Inc.(New Haven, CT), Yale University (New Haven, CT) Appl.
No.: 11/064,533 Filed:...
